A potent angiogenesis-inhibitory compound TAN-1120 was found to be produced by a Streptomyces species isolated from a soil sample. The producing organism was characterized as a newsubspecies of S. triangulatus and namedS. triangulatus subsp. angiostaticus subsp. nov. due to its specific ability to produce the compound. This substance was isolated as a red powder by a combination of organic solvent extraction, silica gel column chromatography and preparative HPLCusing an ODScolumn. Its structure was elucidated by chemical reactions and spectral analyses to be a new baumycin-group anthracycline. Reduction of TAN-1 120 gave two compounds, a deoxy derivative and baumycin Al. TAN-1120 showed remarkably potent angiostatic activity in two conventional angiogenesis assay systems in vivo, while doxorubicin and daunomycin had far weaker activity. It strongly inhibited proliferation of vascular endothelial cells but did not prevent capillary cord formation in vitro by the endothelial cells on extracellular matrix-coated plates. TAN-1120 is one of the most potent angiostatic agents reported.
Intensive and aberrant neovascularization has been observed to be associated with various pathological conditions, such as diabetic retinopathy, trachoma, psoriasis, hemangioma, rheumatoid arthritis, atherosclerosis and solid tumors1*. In 1971, J. Folkman presented the anti-angiogenesis hypothesis that since solid tumor growth is angiogenesis-dependent, anti-angiogenesis therapy should be a potentially promising approach2). Since then, angiogenesis inhibitors have been sought after as a new type of antitumor agents. During our screening program focusing on such inhibitors, we found that the Streptomyces strain inositol, but L-arabinose, D-xylose, D-glucose, D-fructose, sucrose, L-rhamnose, raffinose and D-mannitol. 2,6-Diaminopimelic acid in hydrolysate of the whole cells was of the ix-type. The above gross characteristics show that strain S-14519 belongs to the genus Streptomyces. Our extensive survey of the previously described Streptomyces species having triangular spores and bluishcolored aerial mycelia led to the conclusion that this strain is most closely related to S. triangulatus described by researchers of Meiji Seika Kaisha, Ltd., Japan11*. Direct comparison of S. triangulatus IFO 13799, which they deposited at Institute for Fermentation, Osaka, with our strain showed that while minor differences were seen in the growth on glycerol -asparagine agar and tyrosine agar, they were almost identical in other respects. However, production of TAN-1120 was not observed with this IFO strain under Scanning electron microscopy was performed using a Hitachi model S-570 scanning electron microscope.
Scanning electron microscopy was performed using a Hitachi model S-570 scanning electron microscope. Strain S-14519 was inoculated into 500ml of the seed medium described below and cultivated at 28°C for 48 hours on a reciprocal shaker. The whole culture was transferred to 30 liters of the seed mediumin a 50-liter fermentor, and cultivated at 28°C for 48 hours with aeration of 30 liters/minute and agitation of 280rpm. The seed culture thus obtained was transferred to 100 liters of the fermentation mediumdescribed below in a 200-liter fermentor, and fermentation was carried out at 28°C for 90 hours with aeration of 100 liters/minute and agitation of 150 rpm.
The seed medium consisted of glucose 2%, soluble starch 3%, corn steep liquor 1%, raw soybean flour 1%, peptone 0.5%, NaCl 0. 3% and CaCO3 (precipitated) 0.5%, pH 7.0. The fermentation medium consisted of glucose 5.5%, corn gluten meal 3. 5% and CaCO3 (precipitated) 0.7%, pH 7.0.
Isolation
MeOH(180 liters) was added to the culture broth (90 liters) after adjustment to pH 6.6, and the mixture was stirred for 30 minutes. After filtration, the filtrate was concentrated to remove MeOH. The aqueous solution thus obtained was washed with EtOAc(2 x 20 liters at pH 5.0 and then extracted with «0-BuOH (2x7.5 liters).
The iso-BuOH layers were combined (13 liters) and washed with 2% aq. APR. 1993 NaHCO3(2 x 3 liters) and water (2 x 6 liters) successively and then concentrated to give an oily residue. The residue was washed with ethyl ether (500ml) and then extracted with CHC13(3 x 500ml). The CHC13 layers were combined and concentrated to give an oily residue (2.3 g).
The residue was chromatographed on a column of silica gel (Merck Silica gel 60, 40g), eluting with CHC13-MeOH-AcOH(97 : 2 : 1). The fraction containing TAN-1120 was washed with 2% aq. NaHCO3 and concentrated to give a red powder (430mg). A 150mgportion of the powder was divided into three portions, and each 50mgwas individually purified by preparative HPLC(column, YMC-Pack SH-343 ODS; mobile phase, 40% CH3CN-50mM phosphate buffer (pH 3.0); flow rate, 10ml/minute). Pure fractions were combined (60ml) and concentrated to remove CH3CN.The aqueous solution (25ml) was extracted with CHC13(2 x 15ml) at pH 7.2, The CHC13 layers were combined and washed with water (15ml), diluted with MeOH(100ml) and concentrated to give TAN-1120 as a dark red powder (14.5mg).
Characterization and Structure Elucidation The chromatographic properties of TAN-1120upon TLCand HPLCare shown in Table 2 along with those of daunomycin. The physico-chemical properties of TAN-1120 are summarized in Table 3 . Its UVspectrum was typical for anthracyclines such as daunomycin. It gave ion peaks at m/z 694 (M +Na)+ in the secondary ion mass (SI-MS) spectrum and at m/z 653 (M+-H2O) in the field desorption mass (FD-MS) spectrum. The molecular formula was deduced to be C34H41NO13from these mass spectra, the 13C NMRspectrum and elemental analysis. Although TAN-1120 was labile in various solvents, the lH and 13C NMRspectra could be recorded in a mixture of CDC13-CD3OD (2 : 1) in which it stably exists in a carbinolamine form (Tables 4 and 5 ). The *H NMRspectrum was similar to that of barminomycin Al (SN-07 chromophore)8'9) except for a methoxy signal at Su 4.09 suggesting the presence of a methoxyl group at the C-4 position. The methine signal at SH3.76 is characteristic of a carbinolamine structure which was supported by the methine signal at Sc 94.3 in the 13C NMRspectrum. These findings indicated that TAN-1 120 is a 4-0-methyl derivative Solvent II, CHC13 -MeOH-toluene (7 : 3 : 3).
of barminomycins.
To confirm the structure, TAN-1120 was reduced with sodium cyanoborohydride and, in a manner similar to that seen with barminomycins8'9), yielded red powders of2 and 3. 2: FD-MS m/z 655 (M+); UV /^ea?H (e) 233 (36,000), 251 (27,200) , 287 2 showed a molecular ion peak at m/z 655 (M+) in FD-MS,and the carbinolamine moiety was changed to a nitrogen bearing methylene (SH 2.77 dd, 2.66 dd; Sc 52.8 t). These findings indicated that 2 is a cyclic deoxy derivative. The other product (3) had a molecular ion peak at m/z 614 (M + H)+ in FD-MS, and the carbinol amine moiety was changed to an oxygen bearing methylene (SH 3.53 dd, 3.42 dd; Sc 66.8 t). Although we have not made a direct comparison, 3 is considered to be identical to baumycin Al3)4) based upon the FD-MS, UV, IR, XHand 13C NMRspectra, and specific rotation. The chromatographic properties of 2 and 3 are listed in Table 2 . Carminomycin III (identical to 4-hydroxybaumycin Al) has been reported to have the (3"S,5"S)-configuration14); hence, TAN-1120 should also have the same configuration as depicted in Fig. 1 .
Biological Activities Angiostatic Activity
In the CAMassay16) which is widely used as the most conventional angiogenesis assay system in vivo, TAN-1120 showed remarkably potent angiostatic activity under a wide range of comparatively low doses up to lO ng/disk without causing tissue damage (Fig. 4) . While the commonanthracyclines such as daunomycin and doxorubicin also showed this activity, their potency was far weaker than that of TAN-1120; the ED50 values of TAN-1120, daunomycin and doxorubicin were 0.046, 1750 and 560 ng/disk, respectively. In addition, the inhibitory dose ranges of daunomycin and doxorubicin were quite narrow in comparison with that of TAN-1120 (Fig.  4) . One tenth /ig/disk of TAN-1120 and 10 /ig/disk of daunomycin or doxorubicin were toxic to the chick embryos. The angiostatic activity of 
20,000 Inflammation
The rat corneal micropocket assay was performed according to the method of Gimbrone et al.16) . Briefly, an ethylene-vinyl acetate copolymer (EVA) pellet containing 250ng of bovine basic fibroblast growth factor (bFGF) (R&D systems) was implanted into a cornea of an adult male Sprague-Dawley rat (Charles River). Another EVApellet with or without a sample wasimplanted between the above pellet and the rat limbus. Ten days after implantation, the corneas were examined for capillary growth from the limbi under a stereoscope (SMZ-10, Nikon) at a magnification of 20. The CAMassay was carried out by the method reported by R. Crum et al.15 ) with some modification.
Briefly, Day-3 eggs were cracked, and the embryos were placed onto hammocksof polyethylene sheets hanging in plastic cups and then incubated at 37°C under 3%CO2 and saturated humidity for a further 6 days. On Day-9, methylcellulose (4000 Centipoise, Wako Pure Chemicals Co.) disks containing samples were placed on the CAM.After incubation for 2 days, responses induced by the samples were examined under a stereoscope Nikon) . The values represent the meansof three separate experimentsin each of which 21 samples were tested for each dose. the reduction products of TAN-1120, the deoxy derivative (2) and baumycin Al (3)4) (Fig. 1) , was one tenth of that of the parent compoundwhen evaluated in terms of ED50 values (data not shown).
In the rat corneal micropocket assay16), 0.2fig of TAN-1120 prevented capillary outgrowth induced by 250ng ofbFGF which is one of the most potent angiogenic factors known1* (Table 6 and Fig. 5 ). At the dose of 20^g/pellet, however, inflammatory responses were observed.
Cytotoxic Activity Against ECs
To gain insight into the mechanism of the angiostatic action of TAN-1 120, we first examined its cytotoxic activity against ECs, because proliferation of ECs is one of the most important steps in angiogenesis1>17).
As shown in Fig. 6, TAN-1120 had a remarkably potent inhibitory effect on the growth of bovine fetal heart ECs CRL-139518).
Moreover, this activity was highly specific to the ECs, since the mouse fibroblast BALB3T3/A31 cells used as a comparative cell line were much less sensitive to this compound (Fig. 6) . Cytotoxic activity of TAN-1120against various human tumor cell lines was 103 to 104 times more potent than that of daunomycin and doxorubicin, and the activity of the deoxy derivative (2) was one tenth of that of the parent compound(data not shown). ) and 30/xg/ml of gentamicin (Sigma) were plated in each well of a 24 well-plate. After incubation at 37°C under 5% CO2 for 24 hours, 25 /il ofa sample solution was added to each well. Two days later, the cells were counted with a Coulter counter (Coulter Electronics, Inc.). The mediumwas supplemented with human recombinant bFGF(Takeda Chem. Ind., 25ng/ml) for the culture of the endothelial cells.
Effect on Angiogenesis In Vitro
Several authors have described that in appropriate experimental conditions, ECs sprout to form à", TAN-1120; n, ansamitocin P3; å , vincristine.
The triangles (V) represent the IC50 values which were obtained from the cell proliferation assay using HUVE cells.
The procedure described in ref 21 was followed with slight modification. Briefly, 2 ml of human umbilical vein endothelial (HUVE) cell suspension (1 x 105 cells/ ml) in Ml99 medium (Gibco Laboratories) with 20% fetal bovine serum and 30/ig/ml of gentamicin was added to each well of a 24-well plate precoated with 200ii\ of Engelbreth-Holm-Swarn tumor extract (12mg protein/ml) overnight at 37°C. Immediately after plating, 25^1 ofa sample solution or 40% MeOH solution as a control was added to the culture. After overnight incubation at 37°C under 3% CO2, the wells were examined for capillary cord formation under a phase-contrast microscope (Olympus), and several fields in each well were photographed. Crossing points on the microphotographs covered with a transparent plastic plate with appropriate grids were counted to quantitate the degree of cord formation as described by Tsuruoka et al.22) . examined the effect of TAN-1120 on this process using HUVE cells in the rapid assay system reported by Kubota et al.21) . TAN-1 120 showed no inhibitory activity in a wide range of concentration even higher than the IC50 (0.7pg/ml) obtained in the cell proliferation assay (Fig. 7) . In contrast, the microtuble inhibitors such as vincristine23) and ansamitocin P324) prevented this process at their respective IC50 concentrations (Fig. 7) .
Antibacterial Activity
As shown in Table 7 , TAN-1120 showed potent antibacterial activity against a wide range of pathogenic bacteria including Pseudomonas aeruginosa.
Discussion
Recently, angiogenesis inhibitors have been receiving a great deal of attention as agents to manage "angiogenic deseases" in which aberrant neovascularization contributes to the pathological state1>26'27).
In this context, such inhibitors have been sought after, and several proteineous inhibitors, mainly from animal avascular tissues such as cartillage28) and eye tissues29), have been reported. In 1983, J. Folkman et al. reported that a class of steroids which they coined "angiostatic steroids"15) inhibits angiogenesis and causes regression of solid tumors in the presence of heparin or a heparin fragment30 characterization of the producer indicated that it is a new subspecies of S. triangulatus11}, and was named subsp. angiostaticus because of its specific ability to produce TAN-1120. Although several species of Streptomyces and Actinomadura have been reported as producers of the baumycin-group anthracyclines3~10), the TAN-1 120 producer is distinct. It is interesting that all anthracycline compounds produced by Streptomyces species have a methoxyl substituent at the 4-position of the anthracycline nucleus, whereas those produced by Actinomadura species do not have this substituent at this position3~10). Since Connors et al. very recently clarified using Streptomyces species that 4-O-methylation is the last step in the biosynthesis of daunomycin31), Actinomadura species seem to commonlylack 4-O-methyltransferase.
Among the baumycin-group anthracyclines, carminomycins6'14) D326 compounds7*, barminomycins8) (SN-07 chromophore9)) and SN-7061O) have a hydroxyl group at the C-4 position. Although only baumycins3>4) have the methoxyl substituent at the C-4 position, their C-6" group is a hydroxymethyl (Al and A2) or a carboxylic acid (Bl and B2). Therefore, TAN-1120 is a new baumycin-group anthracycline having the methoxyl group at the C-4 position and the carbinolamine group in the sugar moiety. Kimuraet al. reported that the SN-07 chromophore is in equilibrium with the aldehyde, carbinolamine, imine and enamine forms32). Although we observed such structural alteration of TAN-1120on HPLC, the carbinolamine form was found to be dominant and stable in MeOH solution.
In general, baumycin-group anthracyclines having the carbinolamine moiety are more potent in both cytotoxicity and antitumor activity than the classical anthracyclines, such as daunomycin and doxorubicin, lacking this moiety3~10). While TAN-1120was discovered as an angiogenesis inhibitor, its cytotoxic activity is also far more potent than that of daunomycin and doxorubicin which were used as the comparative compounds in this study. Furthermore, its angiostatic activity in the CAMassay was also remarkably strong in comparison with that of the control antibiotics (Fig. 4) .
It is well established that angiogenesis in vivo proceeds in several distinct steps such as proliferation and migration of ECs, vascular cord formation, canalization of the cords, and maturation of the basement membrane surrounding the newly formed vessel walls1*. Amongthem, vascular cord formation is a very unique differentiation process of ECs1>20). However, TAN-1120did not have any inhibitory effect on this process even at concentrations higher than its growth inhibitory concentration (Fig. 7) . Since the microtubule inhibitors strongly inhibited this process at their respective IC50 values, reassembly of cytoskeltons in the ECs seems to take place in this process33).
In conclusion, TAN-1120seems to be a promising angiostatic agent, since complete inhibition without any sign of tissue damage was observed under a wide range of low doses, 0.01~lOng/disk, in the CAMassay (Fig. 4) and since it showed highly specific inhibition of proliferation of the ECs (Fig. 6) . The deoxy derivative was one tenth as active as the parent compoundin cytotoxic and angiostatic activity. TAN-1120 had also an extensive antibacterial spectrum (Table 7) . It is clear that the activity against Gram-negative bacteria is dependent on the presence of the carbinolamine moiety attached to daunosamine, since barminomycin I is active but carbinomycin III is not8). Until now, fumagillin and its analogues34~36), a sulfated polysaccharide -peptidoglycan complex37), herbimycin A38), eponemycin39) and staurosporin40) have been reported as angiogenesis inhibitors of microbial origin. Although the precise mechanism of the angiostatic action of TAN-1120 remains to be elucidated, this substance seems to be the most potent angiogenesis inhibitor known to date.
